Using the MS-SRM method established, 118 FFPE samples from patients in northern China with advanced gastric adenocarcinoma were evaluated for HER2 expression, and the results were compared to the guideline IHC and FISH methods. The gene discussed is ERBB2; the disease is gastric adenocarcinoma.